| Product Code: ETC12986863 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Natural Killer Cell Therapeutics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Natural Killer Cell Therapeutics Market - Industry Life Cycle |
3.4 Israel Natural Killer Cell Therapeutics Market - Porter's Five Forces |
3.5 Israel Natural Killer Cell Therapeutics Market Revenues & Volume Share, By Therapeutic Type, 2021 & 2031F |
3.6 Israel Natural Killer Cell Therapeutics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Israel Natural Killer Cell Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Israel Natural Killer Cell Therapeutics Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.9 Israel Natural Killer Cell Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Natural Killer Cell Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and infectious diseases in Israel |
4.2.2 Rising investments in research and development of natural killer cell therapeutics |
4.2.3 Growing awareness about the benefits of natural killer cell therapy |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of natural killer cell therapeutics |
4.3.2 High cost associated with the development and production of natural killer cell therapies |
5 Israel Natural Killer Cell Therapeutics Market Trends |
6 Israel Natural Killer Cell Therapeutics Market, By Types |
6.1 Israel Natural Killer Cell Therapeutics Market, By Therapeutic Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Therapeutic Type, 2021 - 2031F |
6.1.3 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By CAR-NK Therapy, 2021 - 2031F |
6.1.4 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Allogeneic NK Cells, 2021 - 2031F |
6.1.5 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Autologous NK Cells, 2021 - 2031F |
6.1.6 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By NK Cell Engagers, 2021 - 2031F |
6.1.7 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Gene-Modified NK Cells, 2021 - 2031F |
6.2 Israel Natural Killer Cell Therapeutics Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Genetic Engineering, 2021 - 2031F |
6.2.3 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Cell Culture, 2021 - 2031F |
6.2.4 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Cell Expansion, 2021 - 2031F |
6.2.5 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Antibody Engineering, 2021 - 2031F |
6.2.6 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By CRISPR-Cas9, 2021 - 2031F |
6.3 Israel Natural Killer Cell Therapeutics Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Cancer Treatment, 2021 - 2031F |
6.3.3 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.3.4 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.3.5 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Autoimmune Disorders, 2021 - 2031F |
6.3.6 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Solid Tumors, 2021 - 2031F |
6.4 Israel Natural Killer Cell Therapeutics Market, By Delivery Method |
6.4.1 Overview and Analysis |
6.4.2 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.4.3 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Injection, 2021 - 2031F |
6.4.4 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Infusion, 2021 - 2031F |
6.4.5 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By IV Drip, 2021 - 2031F |
6.4.6 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.5 Israel Natural Killer Cell Therapeutics Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5.3 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5.4 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.5.5 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.5.6 Israel Natural Killer Cell Therapeutics Market Revenues & Volume, By Biotech Startups, 2021 - 2031F |
7 Israel Natural Killer Cell Therapeutics Market Import-Export Trade Statistics |
7.1 Israel Natural Killer Cell Therapeutics Market Export to Major Countries |
7.2 Israel Natural Killer Cell Therapeutics Market Imports from Major Countries |
8 Israel Natural Killer Cell Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials involving natural killer cell therapeutics in Israel |
8.2 Investment trends in the natural killer cell therapy sector in Israel |
8.3 Adoption rate of natural killer cell therapies in clinical settings |
9 Israel Natural Killer Cell Therapeutics Market - Opportunity Assessment |
9.1 Israel Natural Killer Cell Therapeutics Market Opportunity Assessment, By Therapeutic Type, 2021 & 2031F |
9.2 Israel Natural Killer Cell Therapeutics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Israel Natural Killer Cell Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Israel Natural Killer Cell Therapeutics Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
9.5 Israel Natural Killer Cell Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Natural Killer Cell Therapeutics Market - Competitive Landscape |
10.1 Israel Natural Killer Cell Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Israel Natural Killer Cell Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here